Boston, Mass. (Sept. 29, 2021) — LifeNet Health is highlighting its advanced solutions for fusion during the North American Spine Society (NASS) 2021 Annual Meeting in Boston Sept. 29-Oct. 1 (Booth #2719).
Boston, Mass. (Sept. 28, 2021) — LifeNet Health, the world leader in allograft biologics, has optimized its industry-leading cellular bone matrix for minimally invasive surgery with the launch of ViviGen® MIS Delivery System, a major improvement in precision, efficiency and reliability over traditional bone-graft delivery.
San Diego, Calif. (Aug. 31, 2021) — LifeNet Health, the world’s leading provider of allograft biologics, is showcasing its comprehensive portfolio of advanced biomaterials at the 2021 AAOS Annual Meeting (Booth #1527) Sept. 1-3.
VIRGINIA BEACH, Va. (June 2, 2021) — LifeNet Health, the federally designated Organ Procurement Organization (OPO) that facilitates organ donation and transplantation throughout Virginia, is collaborating with the United Network for Organ Sharing (UNOS) to improve the way organs are transported in the United States.
VIRGINIA BEACH, Va. (April 7, 2021) — While in college, Curt Holland was diagnosed with a condition called hypertrophic cardiomyopathy – or as Curt put it, he had a “big fat heart.” At first it didn’t slow him down, but by the time he was 50, he began getting fatigued more easily. Everything from exercising to simply checking the mail was becoming more challenging. He needed a heart transplant.
VIRGINIA BEACH, Va. (March 12, 2021) — LifeNet Health, Virginia’s federally designated Organ Procurement Organization (OPO), is launching a campaign focused on building support for organ and tissue donation among Black Virginians in the Richmond area with plans to expand the focus across the Commonwealth. The One Hero campaign will share information about the critical need for Black organ and tissue donors and will address misconceptions around donation that have kept registration rates low in these communities.
VIRGINIA BEACH, Va. (March 12, 2021) — LifeNet Health LifeSciences will showcase its portfolio of innovative human cell- and tissue-based research solutions — including the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes — at the Society of Toxicology (SOT) virtual annual meeting and ToxExpo at booth #1322. LifeSciences provides researchers human-relevant research solutions to optimize outcomes and speed the drug discovery process.
Virginia Beach, Va., (Feb. 23, 2021) —Training Magazine, a leading business publication for workforce development programs, has recognized LifeNet Health for the second consecutive year as one of the world’s leading organizations for employee training. Last year, LifeNet Health’s ranking was placed at 70 and this year moved up to 34 out of 100 organizations.
VIRGINIA BEACH, Va. (Feb. 3, 2021) — LifeNet Health LifeSciences has successfully isolated three types of primary human lung epithelial cells from a single donor. One of the three types, alveolar epithelial type II cells, are of particular interest to scientists due to their applicability for respiratory disease research. LifeNet Health’s scientists have also isolated the bronchial and small airway epithelial cells, which are critical for the first lines of defense in protecting the lungs.
VIRGINIA BEACH, Va. (Jan. 13, 2021) — LifeNet Health announced today the launch of their newly expanded LifeSciences division which is offering human cell- and tissue-based research solutions through a new website, LNHLifeSciences.org.